A detailed history of Gwn Securities Inc. transactions in Cel Sci Corp stock. As of the latest transaction made, Gwn Securities Inc. holds 1,191,177 shares of CVM stock, worth $262,058. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,191,177
Holding current value
$262,058
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$0.23 - $0.45 $273,970 - $536,029
1,191,177 New
1,191,177 $287 Million

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $9.54M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Gwn Securities Inc. Portfolio

Follow Gwn Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gwn Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gwn Securities Inc. with notifications on news.